BamSEC and AlphaSense Join Forces
Learn More

Oruka Therapeutics Inc.

NASDAQ: ORKA    
Share price (12/20/24): $20.31    
Market cap (12/20/24): $711 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.2
from 8-K 1 page Amendment No. 1 to Placement Agency Agreement Dated January 21, 2014
12/34/56
EX-1.1
from 8-K 25 pages Placement Agency Agreement January 21, 2014
12/34/56
EX-1.1
from S-1/A 17 pages Confidential Michael Bristow Chief Executive Officer ARCA Biopharma, Inc. 8001 Arista Place, Suite 430 Broomfield, Colorado 80021 Dear Mr. Bristow
12/34/56
EX-1.1
from S-1/A 17 pages Confidential Michael Bristow Chief Executive Officer ARCA Biopharma, Inc. 8001 Arista Place, Suite 430 Broomfield, Colorado 80021 Dear Mr. Bristow
12/34/56
EX-1.1
from 8-K 25 pages Placement Agency Agreement
12/34/56
EX-1
from SC 13D ~1 page Agreement
12/34/56
EX-1.1
from 8-K 25 pages Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 33 pages Placement Agency Agreement April 18, 2011
12/34/56
EX-1.1
from 8-K 36 pages Nuvelo, Inc. 6,500,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Underwriting Agreement Dated February 1, 2005 Nuvelo, Inc. 8,500,000 Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages Nuvelo, Inc. 5,000,000 Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages 10,000,000 Shares Nuvelo, Inc. Common Stock Underwriting Agreement Dated October 2, 2003 Jmp Securities LLC
12/34/56
EX-1
from 8-K ~50 pages Rights Agreement
12/34/56
EX-1
from SC 13D ~20 pages Stock Purchase Agreement
12/34/56
EX-1.1
from S-1/A ~50 pages Form of Underwriting Agreement
12/34/56